Clinical Management of Patients with CABOMETYX® (cabozantinib) + OPDIVO® (nivolumab)

Exelixis
September 14, 2021
 

If you are interested in learning more about CABOMETYX® (cabozantinib) + OPDIVO® (nivolumab), please join our educational presentation: Clinical Management of Patients with CABOMETYX® (cabozantinib) + OPDIVO^® (nivolumab) on September 14, 2021 at 5:00PM EST

• Disease State Overview
• Combination treatment for appropriate patients
• Dosing and administration information, including dose adjustment guidance
• Management of select adverse reactions
• Support information and access services